Using an estradiol patch while taking a GLP-1 medication

What GLP-1 medications do to the stomach

Semaglutide and tirzepatide slow the rate at which food leaves your stomach. That is part of why they reduce appetite, and it is also why they can change how quickly and how completely you absorb medications you swallow.

The Wegovy label notes that this delay has the potential to affect the absorption of oral medications taken at the same time, and advises closer monitoring for drugs where small changes matter.

What the labels say about hormones

Tirzepatide has the clearest data. In the Zepbound label, a single dose reduced peak levels of a combined oral contraceptive by about half or more and lowered overall exposure by roughly a fifth. The label advises women using oral hormonal contraceptives to switch to a non-oral method, or add a barrier method, for four weeks after starting tirzepatide and for four weeks after each dose increase. It also states that hormonal contraceptives that are not taken by mouth should not be affected.

For semaglutide, the Wegovy label reports no clinically significant change in ethinyl estradiol or levonorgestrel levels in its interaction studies.

Neither label includes studies with menopausal hormone therapy. Contraceptive estrogen and menopausal estradiol are different products at different doses, so these results hint at a possible effect on oral HRT but do not prove one. The honest summary is that the data are missing, not that the combination is known to be fine.

Why the patch sidesteps the issue

An estradiol patch releases hormone through your skin directly into the bloodstream. Your stomach is not involved, so slower emptying has no reason to change your dose. The same is true for estradiol gels and sprays.

There is a second reason the patch suits many women on GLP-1s. People prescribed these medications often have higher body weight, which raises clot risk, and large observational studies have found that transdermal estrogen, unlike oral estrogen, is not clearly associated with more venous clots.

The progesterone question

If you have a uterus, you need a progestogen to protect the uterine lining, and the progestogen with the best track record for that job, micronized progesterone, is usually taken as a capsule. Skin-applied progesterone has not been shown to provide reliable protection.

So most women on a GLP-1 still take oral progesterone. If absorption were reduced, the theoretical concern would be weaker protection of the lining. That has not been demonstrated, but it is a reason to report any unexpected bleeding or spotting promptly.

Signs your hormone dose may be off

Tell your clinician if you notice any of these after starting a GLP-1 or increasing its dose:

• Hot flashes or night sweats returning after they had settled
• Sleep getting worse again without another obvious cause
• New spotting or bleeding, or a change in a predictable bleeding pattern
• Vomiting or diarrhea that lasts more than a day or two, which can affect any oral medication

Other things to keep in mind

Weight loss itself can change how you feel on hormone therapy. Some women find symptoms ease as weight falls; others need a dose adjustment. Your clinician reviews this at follow-up rather than assuming either way.

GLP-1 medications carry their own warnings, including common nausea and other stomach upset, a boxed warning about thyroid C-cell tumors (they are not used in people with a personal or family history of medullary thyroid cancer or MEN2), and risks of pancreatitis and gallbladder problems. Make sure every prescriber you see knows you take both.

How HealifyMD coordinates the two

If you get both your hormone therapy and your weight medication through HealifyMD, your clinicians can see the full picture. If one is prescribed elsewhere, tell us when you start a GLP-1, change its dose or stop it.

In practice, our clinicians often suggest the estradiol patch for women on a GLP-1, check in on symptoms and bleeding after each GLP-1 dose change, and keep oral progesterone in the plan when the uterus is present. The patch is included in the hormone therapy program ($349 first month, then $99/month). Compounded GLP-1 medications are not FDA-approved and are not equivalent to Wegovy or Zepbound.